Cost-effectiveness analyses of denosumab for osteoporosis: a systematic review
Cost-effectiveness analyses of denosumab for osteoporosis: a systematic review
About this item
Full title
Publisher
London: Springer London
Journal title
Language
English
Formats
Publication information
Publisher
London: Springer London
Subjects
More information
Scope and Contents
Contents
Summary
This paper systematically reviewed and assessed all retrievable pharmacoeconomic studies on denosumab for the treatment of osteoporosis. Denosumab was more cost-effective in patients with older age, prior fracture experience, lower BMD T-scores, and more risk factors. ESCEO-IOF guidelines were more applicable to improve the quality of ph...
Alternative Titles
Full title
Cost-effectiveness analyses of denosumab for osteoporosis: a systematic review
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_miscellaneous_2622281013
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_2622281013
Other Identifiers
ISSN
0937-941X
E-ISSN
1433-2965
DOI
10.1007/s00198-021-06268-9
